Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
Completed
Conditions studied: Polyomavirus
In brief
Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant biopsies of patients affected by polyomavirus.
Key facts
- Study ID
- NCT00374283
- Run by
- University of Cincinnati
- People needed
- 40
- Starts
- 2001-06-01
- Expected to finish
- 2007-10-01
- Last updated by the study team
- 2008-01-03
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven interstitial nephritis due to polyomavirus.
- Age 18 to 70 years.
- Capable of providing written informed consent.
You may not qualify if…
- Age less than 18 years or greater than 70 years.
- Patient is on chronic warfarin or heparin therapy or has a disease that puts them at risk of bleeding.
Where it is running
- The Christ Hospital — Cincinnati, Ohio, United States
- University of Cincinnati — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.